Platelets and circulating (tumor) cells: partners in promoting metastatic cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Platelets protect circulating tumor cells (CTCs) from the harsh bloodstream environment, aiding metastasis. Targeting platelet-CTC interactions with antiplatelet therapy may inhibit cancer spread and improve outcomes.
Area Of Science
- Oncology
- Hematology
- Cancer Metastasis Research
Background
- Metastasis remains a significant challenge in cancer treatment.
- Circulating tumor cells (CTCs) are tumor cells in the bloodstream, and their numbers correlate with poor prognosis.
- The survival mechanisms of CTCs in the hostile blood environment are not fully understood.
Purpose Of The Study
- To review current clinical methods for enumerating CTCs.
- To explore the role of platelet-CTC interactions in CTC survival and metastasis.
- To discuss antiplatelet therapy as a potential strategy to inhibit metastasis.
Main Methods
- Literature review of clinical methods for CTC enumeration.
- Analysis of laboratory and clinical data on platelet-CTC crosstalk.
- Review of current research on antiplatelet therapy in cancer metastasis.
Main Results
- Platelets promote the survival of CTCs in the bloodstream.
- Advanced CTC enumeration techniques provide improved prognostic value.
- Understanding platelet-CTC interactions offers therapeutic insights.
Conclusions
- Platelet-CTC interactions are crucial for CTC survival during metastasis.
- Targeting these interactions, potentially via antiplatelet therapy, could inhibit metastasis.
- Further research into this crosstalk may lead to novel cancer treatment strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...